SCHEDULE 13D

Company

LIFECORE BIOMEDICAL, INC. \DE\

Filed

February 6, 2009

Accession Number

0001005477-09-000528

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →